Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 25Neoplasms 12Stomach Neoplasms 10Endometrial Neoplasms 10Lung Neoplasms 9Lymphatic Metastasis 7Melanoma 6Head and Neck Neoplasms 6Carcinoma, Hepatocellular 6Uterine Cervical Neoplasms 5Rectal Neoplasms 5Esophageal Neoplasms 5Colonic Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Vulvar Neoplasms 3Sarcoma 3Prostatic Neoplasms 3Ovarian Neoplasms 3Colorectal Neoplasms 3Thyroid Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Skull Base Neoplasms 2Sarcoma, Ewing 2Rhabdomyosarcoma 2Peritoneal Neoplasms 2Osteosarcoma 2Margins of Excision 2Lymphedema 2Hypoparathyroidism 2Giant Cell Tumor of Bone 2

Interventions

Saline Solution 1Negative-Pressure Wound Therapy 1Indocyanine Green 1Glucose Tolerance Test 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Graves Disease × Indocyanine Green × Clear all
NCT03969108 2020-03-27

Diagnostic Accuracy Study of Indocyanine Green for Parathyroid Perfusion Assessment

University Health Network, Toronto

Phase 4 Completed
10 enrolled
Head & Neck

Goiter, Graves Disease, Hypoparathyroidism, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡